Annual Interest Expense
$137.31 K
+$97.90 K+248.39%
31 December 2023
Summary:
Sunshine Biopharma annual interest expense is currently $137.31 thousand, with the most recent change of +$97.90 thousand (+248.39%) on 31 December 2023. During the last 3 years, it has fallen by -$30.80 thousand (-18.32%). SBFMW annual interest expense is now -58.24% below its all-time high of $328.82 thousand, reached on 31 December 2021.SBFMW Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$0.00
-$245.00-100.00%
30 September 2024
Summary:
Sunshine Biopharma quarterly interest expense is currently $0.00, with the most recent change of -$245.00 (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$38.53 thousand (-100.00%). SBFMW quarterly interest expense is now -100.00% below its all-time high of $258.02 thousand, reached on 31 December 2015.SBFMW Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$79.54 K
-$38.53 K-32.63%
30 September 2024
Summary:
Sunshine Biopharma TTM interest expense is currently $79.54 thousand, with the most recent change of -$38.53 thousand (-32.63%) on 30 September 2024. Over the past year, it has dropped by -$54.21 thousand (-40.53%). SBFMW TTM interest expense is now -83.10% below its all-time high of $470.55 thousand, reached on 31 December 2015.SBFMW TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +248.4% | -100.0% | -40.5% |
| 3 y3 years | -18.3% | -100.0% | -80.0% |
| 5 y5 years | -13.9% | -100.0% | -37.5% |
SBFMW Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -58.2% | +248.4% | -100.0% | -80.0% | +101.8% | |
| 5 y | 5 years | -58.2% | +248.4% | -100.0% | -80.0% | +101.8% | |
| alltime | all time | -58.2% | -100.0% | -83.1% |
Sunshine Biopharma Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | $79.54 K(-32.6%) |
| June 2024 | - | $245.00(-99.5%) | $118.06 K(-18.8%) |
| Mar 2024 | - | $49.18 K(+63.3%) | $145.41 K(+5.9%) |
| Dec 2023 | $137.31 K(+248.4%) | $30.11 K(-21.8%) | $137.31 K(+2.7%) |
| Sept 2023 | - | $38.53 K(+39.6%) | $133.74 K(+40.5%) |
| June 2023 | - | $27.60 K(-32.8%) | $95.22 K(+40.8%) |
| Mar 2023 | - | $41.08 K(+54.7%) | $67.62 K(+71.6%) |
| Dec 2022 | $39.41 K(-88.0%) | $26.55 K(>+9900.0%) | $39.41 K(-20.4%) |
| Sept 2022 | - | $2.00(>+9900.0%) | $49.50 K(-48.6%) |
| June 2022 | - | $0.00(-100.0%) | $96.34 K(-67.0%) |
| Mar 2022 | - | $12.86 K(-64.9%) | $291.97 K(-11.2%) |
| Dec 2021 | $328.82 K(+95.6%) | $36.63 K(-21.8%) | $328.82 K(-17.3%) |
| Sept 2021 | - | $46.85 K(-76.1%) | $397.63 K(+6.6%) |
| June 2021 | - | $195.63 K(+293.5%) | $372.87 K(+88.7%) |
| Mar 2021 | - | $49.71 K(-52.9%) | $197.60 K(+20.3%) |
| Dec 2020 | $168.10 K(+45.0%) | $105.44 K(+377.2%) | $164.25 K(+99.7%) |
| Sept 2020 | - | $22.09 K(+8.5%) | $82.23 K(-6.5%) |
| June 2020 | - | $20.36 K(+24.5%) | $87.98 K(+2.4%) |
| Mar 2020 | - | $16.36 K(-30.1%) | $85.96 K(-28.0%) |
| Dec 2019 | $115.90 K(-27.3%) | $23.41 K(-15.9%) | $119.42 K(-6.1%) |
| Sept 2019 | - | $27.85 K(+51.8%) | $127.24 K(+2.8%) |
| June 2019 | - | $18.34 K(-63.2%) | $123.73 K(-7.5%) |
| Mar 2019 | - | $49.81 K(+59.5%) | $133.77 K(-16.1%) |
| Dec 2018 | $159.42 K(+52.1%) | $31.24 K(+28.3%) | $159.42 K(-14.7%) |
| Sept 2018 | - | $24.34 K(-14.2%) | $186.84 K(-1.6%) |
| June 2018 | - | $28.38 K(-62.4%) | $189.93 K(+11.0%) |
| Mar 2018 | - | $75.47 K(+28.7%) | $171.15 K(+63.3%) |
| Dec 2017 | $104.83 K(+201.8%) | $58.66 K(+113.9%) | $104.83 K(+102.3%) |
| Sept 2017 | - | $27.43 K(+185.8%) | $51.82 K(+41.9%) |
| June 2017 | - | $9598.00(+5.0%) | $36.52 K(-1.1%) |
| Mar 2017 | - | $9144.00(+61.8%) | $36.92 K(+6.3%) |
| Dec 2016 | $34.73 K | $5652.00(-53.4%) | $34.73 K(-87.9%) |
| Sept 2016 | - | $12.13 K(+21.3%) | $287.11 K(+0.8%) |
| June 2016 | - | $9997.00(+43.8%) | $284.73 K(-7.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $6954.00(-97.3%) | $307.96 K(-34.6%) |
| Dec 2015 | $307.21 K(+71.5%) | $258.02 K(+2545.1%) | $470.55 K(+96.1%) |
| Sept 2015 | - | $9755.00(-70.6%) | $239.94 K(+2.7%) |
| June 2015 | - | $33.23 K(-80.4%) | $233.61 K(-7.8%) |
| Mar 2015 | - | $169.54 K(+518.4%) | $253.26 K(+41.4%) |
| Dec 2014 | $179.10 K(+2674.5%) | $27.42 K(+701.2%) | $179.10 K(+17.8%) |
| Sept 2014 | - | $3422.00(-93.5%) | $152.05 K(+2.0%) |
| June 2014 | - | $52.88 K(-44.6%) | $149.01 K(+54.4%) |
| Mar 2014 | - | $95.38 K(>+9900.0%) | $96.51 K(+1395.1%) |
| Dec 2013 | $6455.00(+407.5%) | $375.00(0.0%) | $6455.00(-2.0%) |
| Sept 2013 | - | $375.00(0.0%) | $6586.00(0.0%) |
| June 2013 | - | $375.00(-93.0%) | $6586.00(0.0%) |
| Mar 2013 | - | $5330.00(+953.4%) | $6586.00(+417.8%) |
| Dec 2012 | $1272.00(>+9900.0%) | $506.00(+34.9%) | $1272.00(+66.1%) |
| Sept 2012 | - | $375.00(0.0%) | $766.00(+95.9%) |
| June 2012 | - | $375.00(+2243.8%) | $391.00(+2343.8%) |
| Mar 2012 | - | $16.00(>+9900.0%) | $16.00(>+9900.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2010 | - | $0.00(0.0%) | $3575.00(-51.8%) |
| Oct 2009 | - | $0.00(-100.0%) | $7424.00(-20.7%) |
| July 2009 | - | $3575.00(+4.9%) | $9364.00(+30.5%) |
| Apr 2009 | - | $3409.00(+674.8%) | $7177.00(-3.1%) |
| Jan 2009 | - | $440.00(-77.3%) | $7406.00(+6.3%) |
| Oct 2008 | - | $1940.00(+39.8%) | $6966.00(+38.6%) |
| July 2008 | $5026.00(>+9900.0%) | $1388.00(-61.8%) | $5026.00(+38.2%) |
| Apr 2008 | - | $3638.00(>+9900.0%) | $3638.00(>+9900.0%) |
| Jan 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2007 | - | $0.00 | $0.00 |
| July 2007 | $0.00 | - | - |
FAQ
- What is Sunshine Biopharma annual interest expense?
- What is the all time high annual interest expense for Sunshine Biopharma?
- What is Sunshine Biopharma annual interest expense year-on-year change?
- What is Sunshine Biopharma quarterly interest expense?
- What is the all time high quarterly interest expense for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly interest expense year-on-year change?
- What is Sunshine Biopharma TTM interest expense?
- What is the all time high TTM interest expense for Sunshine Biopharma?
- What is Sunshine Biopharma TTM interest expense year-on-year change?
What is Sunshine Biopharma annual interest expense?
The current annual interest expense of SBFMW is $137.31 K
What is the all time high annual interest expense for Sunshine Biopharma?
Sunshine Biopharma all-time high annual interest expense is $328.82 K
What is Sunshine Biopharma annual interest expense year-on-year change?
Over the past year, SBFMW annual interest expense has changed by +$97.90 K (+248.39%)
What is Sunshine Biopharma quarterly interest expense?
The current quarterly interest expense of SBFMW is $0.00
What is the all time high quarterly interest expense for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly interest expense is $258.02 K
What is Sunshine Biopharma quarterly interest expense year-on-year change?
Over the past year, SBFMW quarterly interest expense has changed by -$38.53 K (-100.00%)
What is Sunshine Biopharma TTM interest expense?
The current TTM interest expense of SBFMW is $79.54 K
What is the all time high TTM interest expense for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM interest expense is $470.55 K
What is Sunshine Biopharma TTM interest expense year-on-year change?
Over the past year, SBFMW TTM interest expense has changed by -$54.21 K (-40.53%)